柳和华1 李芳君1,2.新生儿缺氧缺血性脑病血清S-100B蛋白与NBNA评分动态监测
的临床研究[J].现代生物医学进展英文版,2011,11(2):289-292. |
新生儿缺氧缺血性脑病血清S-100B蛋白与NBNA评分动态监测
的临床研究 |
Clinical study of dynamic monitoring of serum S-100B protein levelsin newborns with hypoxic ischemic encephalopathy |
|
DOI: |
中文关键词: 新生儿缺氧缺血性脑病 S-100B蛋白 NBNA评分 |
英文关键词: Hypoxic - ischemic encephalopathy S - 100 p rotein NBNA score |
基金项目: |
|
Hits: 657 |
Download times: 1050 |
中文摘要: |
目的:观察新生儿缺氧缺血性脑病(hypoxic-ischemic encephalopathy ,HIE)血清S-100B 蛋白的动态变化规律,探讨其在HIE
早期诊断中的价值,以及其浓度变化与病情严重程度及预后的关系。同时研究围产期高危因素以及NBNA评分在HIE发生发展
与预后中的作用。方法:30例住院正常新生儿作为对照组,于出生后采血,55例HIE患儿(HIE 组)分别于出生后1 天、2 天、7 天
采血,采用酶联免疫吸附试验、双抗体夹心法检测。收集并分析两组围产期相关资料。HIE组并于采血同时进行NBNA评分。结
果:(1)HIE 患儿生后第一天与第二天血清S-100B 蛋白浓度明显高于对照组(P<0.05),生后第七天轻度HIE 与对照组比较没有
统计意义,中、重度HIE与对照组比较有统计学意义。(2)生后第一天与第二天不同病情组HIE患儿NBNA评分相互比较差异具
有统计学意义(P<0.05),第七天轻、中和重度患儿NBNA评分<35分的患儿分别占33.3%,47.1%,100%。结论:动态监测HIE患
儿血清S-100B蛋白浓度和NBNA评分的变化,对HIE的早期诊断,严重程度的判断以及预后的估计有重要意义。 |
英文摘要: |
Objectives:To investigate the clinical value of S-100B and NBNA score on neonatal with hypoxic ischemic
encephalopathy (HIE) in early judgment and prognosis, and to study the clinica1 significance of perinatal stage high risk factor. Methods:
30 cases of normal neonates as control group, The serum S-100B concentrations were detected in 55 asphyxia newborn at 1st day, 2nd
days and 7th days after birth. Carrying out NBNA score. at the same time. S - 100 protein was measured dynamically by ELASA.
Collectting and analyzing perinatal stage correlated information. Results: (1) The levels of serum S-100B in newborns with HIE were
obviously higher than that in control group at 1st day and 2nd days (P<0.05), No significant differences were observed in the slight
pathologyical change group as compared with the levels of control group at 7th days (P>0.05). (2) To compare NBNA score in
newborns with HIE , there was still significantly different between the different pathogenetic condition at 1st day and 2nd days (P<0.05).
At 7th days, NBNA score<35 was 33.3%,47.1%,100% . Conclusion: It is important for early diagnosis and determination of the
severity and prognosis of HIE to monitor serum S-100B protein levels and NBNA score. |
View Full Text
View/Add Comment Download reader |
Close |